Kristin Ludwig joins BOLDSCIENCE’s leadership team as SVP to lead new BOLDADVOCACY division
February 27, 2024 | Medical Communications, Pharma, advocacy, agency, medcomms, medical affairs, patients, strategic communication
BOLDADVOCACY expands BOLDSCIENCE’s strategic medical communications services into patient advocacy and engagement
Global medical communications agency BOLDSCIENCE has hired healthcare and oncology communications strategist Kristin Ludwig as Senior Vice President (SVP) to lead a new specialty division dedicated to patient advocacy and engagement. The new division, BOLDADVOCACY, will empower progress and elevate patients’ voices throughout the course of clinical development and delivery of innovative medicines.
As the long-time Chief Communications and Marketing Officer for ASCO and recent VP of Global Communication and Patient Affairs for a start-up biotech, Ludwig brings over 30 years’ experience in the medical PR, patient advocacy, public education, and physician engagement space.
Much of Ludwig’s career has centered around informing and empowering people living with cancer. She led the creation of Cancer.Net, ASCO’s award-winning patient information website which educates on 120 cancer types and serves over 47 million visitors a year from around the globe. She developed a series of in-demand print and digital patient education materials for hospital and community resource centers. Furthermore, Kristin has led dozens of nationally recognized public awareness campaigns, and helped organize patient townhalls to address access and equity issues. Over the years, Ludwig has devised a range of initiatives both for, and with, patients advocates and has earned long-standing, trusted relationships with leaders across the patient advocacy community.
“Medical communications, patient advocacy and physician engagement have always been my passion. I am honored to establish this exciting new division at BOLDSCIENCE so I can continue to empower others in the name of faster cures, improved access to medicines, and higher quality care,” Ludwig stated. “I look forward to strategizing with clients, patients, and advocacy groups to provide comprehensive, patient-centric scientific understanding to support mutual medical communications goals.”
Ludwig has an impressive track-record of leading new divisions to success. She established ASCO’s first Communications Department and grew it over time to include media/PR, patient advocacy and education, corporate affairs, and marketing. Her steady leadership and contributions were critical to the growth, impact, and reputation of the Association. In addition, during her tenure, the ASCO Annual Meeting became the leading “must attend” conference for the oncology community.
BOLDADVOCACY will be the second of several specialty divisions this forward-thinking agency has planned for the near future. Led by Ludwig, the BOLDADVOCACY team comprises scientific specialists and client service professionals, and is supported by BOLDSCIENCE’s high-powered creative and digital teams. Services will include strategic patient engagement planning, patient advisory boards, web and digital products, and patient education materials, among others. The team will work across corporate and non-profit enterprises to seamlessly support clients across all functions and throughout the product lifecycle.
Mark Lydiatt, BOLDSCIENCE’s Chief Executive Officer, adds “Kristin brings with her unprecedented engagement experience with key stakeholders and thought leaders across the patient advocacy, oncology and medical space. Under Kristin’s leadership, this division will allow us to continue to build an unrivalled medical communications agency that will not only benefit our clients, but will have a true impact toward improving treatments, quality of life, and patient care.” Adding to this, Alison Lovibond, Chief Scientific Officer, states “BOLDSCIENCE continues to cement its standing as a differentiated scientifically creative medical communications agency – a trusted partner that integrates scientific understanding with patient-centric, cutting-edge capabilities”.
BOLDSCIENCE plans to enlarge the BOLDADVOCACY team in the US and EU as their work continues to grow with clients globally. For further information, please visit www.boldsci.com, or contact us at hello@boldsci.com.
This content was provided by BOLDSCIENCE
Company Details
Latest Content from BOLDSCIENCE
Kristin Ludwig joins BOLDSCIENCE’s leadership team as SVP to lead new BOLDADVOCACY division
BOLDADVOCACY expands BOLDSCIENCE’s strategic medical communications services into patient advocacy and engagement
BOLDSCIENCE launches BOLDAPPROVALS division
BOLDAPPROVALS, a new division of the medical communications agency BOLDSCIENCE, will help pharmaceutical and biotech clients gain regulatory approval with comprehensive services that include preparation for US Food and Drug...
BOLDSCIENCE welcomes Steven Cohen to its leadership team to expand its strategic communication consulting services into regulatory approvals
Medical communications agency BOLDSCIENCE has hired industry veteran Steven Cohen to lead a new division that will help pharmaceutical and biotech clients navigate the most critical challenges they face throughout...
BOLDSCIENCE marks its 1-year launch anniversary with record growth
Specialist medical communication agency BOLDSCIENCE has seen demand for its ‘scientifically creative’ service offerings soar over the past year as global pharma and biotech clients search for trusted partners with...
New medical communications agency BOLDSCIENCE launches
The new global agency boldly sets out its plans to become a major player in med comms